Changes to Havrix booster dose

Changes to the prescribing information for the Havrix Monodose hepatitis A vaccine mean that it is no longer necessary to restart the primary vaccination schedule if the booster is administered within five years of primary vaccination.

Although a booster dose is normally recommended between six to 12 months of primary vaccination, it has been shown that immunocompetent subjects given a booster up to five years after initial vaccination can show a satisfactory antibody response sufficient for persistent immunity.

Further information: GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex UB11 1BT. Tel: (0800) 221441.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...